Screening at the National Cancer Institute
Goldin, A.; Venditti, J.M.; Carter, S.K.
National Cancer Institute Monograph 1977(45): 37-48
1977
ISSN/ISBN: 0083-1921 PMID: 337155 Document Number: 112174
Document emailed within 1 workday
Related Documents
Hoyt, D.B.; Holcomb, J.; Abraham, E.; Atkins, J.; Sopko, G. 2004: Working Group on Trauma Research Program summary report: National Heart Lung Blood Institute (NHLBI), National Institute of General Medical Sciences (NIGMS), and National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH), and the Department of Defense (DOD) Journal of trauma 57(2): 410-415Ngo, L.S.M.; Yeo, A.; Wong, A.S.C.; Tay, M.Hiang. 2007: Efficacy of low-dose ketoconazole in hormone refractory prostate cancer patients at the National Cancer Centre and The Cancer Institute, Singapore Annals of the Academy of Medicine Singapore 36(10): 811-814
Srinithiwat, B.; Ularntinon, S. 2014: Concurrent validity of the Ages & Stages Questionnaires, Third Edition, Thai-version (ASQ-3 Thai) with the Denver Developmental Screening Test II (DDST-II) in developmental screening of 18, 24, and 30 months old children at Queen Sirikit National Institute of Child Health Journal of the Medical Association of Thailand 97 Suppl. 6: S6-13
Raju, T.N.K.; Nelson, K.B.; Ferriero, D.; Lynch, J.Kylan. 2007: Ischemic perinatal stroke: summary of a workshop sponsored by the National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke Pediatrics 120(3): 609-616
Chiarodo, A. 1991: National Cancer Institute roundtable on prostate cancer: future research directions Cancer Research 51(9): 2498-2505
Ornellas, A.A.; Khouri, F.R.; Campos, F.; Koifman, N.; Quirino, R. 1999: Cancer of the urethra in women: experience of the National Institute of Cancer of Brazil: 1992-1997 Progres en urologie: journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 9(2): 292-298
Zwiebel, J. 2016: The effect on drug development of the National Cancer Institute's Cancer Therapy Evaluation Program Clinical Advances in Hematology and Oncology: H&o 14(3): 157-159
Talukder, M.H.; Jabeen, S.; Shaheen, S.; Islam, M.J.; Haque, M. 2007: Pattern of cancer in young adults at National Institute of Cancer Research and Hospital (NICRH), Bangladesh Mymensingh medical journal: MMJ 16(2 Suppl): S28-S33
Churesigaew, S.; Ratrisawasdi, V.; Thaeramanophab, S. 2002: Thyrotropin screening for congenital hypothyroidism in Queen Sirikit National Institute of Child Health, Thailand (during year 1995-2000) Journal of the Medical Association of Thailand 85(7): 782-788
de Koning, H.J. 1995: Screening for breast cancer, time to think--and stop? National Evaluation Team for Breast Cancer Screening (NETB) Lancet 346(8972): 438-439
van Asperen, C.J.; de Bock, G.H.; van der Horst, F.; de Koning, H.J.; Rutgers, E.J. 2001: Screening for breast cancer on basis of individual risk assessment for women ineligible for the national population screening program Nederlands Tijdschrift Voor Geneeskunde 145(3): 120-125
Vigushin, D.M. 2002: FR-901228 Fujisawa/National Cancer Institute Current Opinion in Investigational Drugs 3(9): 1396-1402
Schepartz, S.A. 1985: The National Cancer Institute's Drug Development Program Progress in Clinical and Biological Research 197: 73-82
Sattin, R W.; Rubin, G L.; Wingo, P A.; Webster, L A.; Ory, H W. 1987: Oral-Contraceptive Use and the Risk of Breast Cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development Obstetric and Gynecologic Survey 42(2): 120-121
Link, D. 1995: New NCI director confronts troubled agency. National Cancer Institute Gmhc Treatment Issues: the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 9(10): 9
Symmans, W.Fraser. 2014: Translational research in the National Cancer Institute's cooperative groups Clinical Advances in Hematology and Oncology: H&o 12(11): 785-787
1987: Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development JAMA 257(6): 796-800
Ivy, S.Percy.; Ivy, S.Percy. 2015: The National Cancer Institute's Experimental Therapeutics Clinical Trials Network Clinical Advances in Hematology and Oncology: H&o 13(3): 144-146
Chabner, B.A.; Curt, G.A.; Hubbard, S.M. 1984: Surgical oncology research development: the perspective of the National Cancer Institute Cancer Treatment Reports 68(6): 825-829
Kaba, H.; Fukuda, H.; Yamamoto, S.; Ohashi, Y. 2004: Reliability at the National Cancer Institute-Common Toxicity Criteria version 2.0 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(8): 1187-1192